Preventive RNAi Medicine(s)
Primary Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)
Key Facts
About Corsera Health
Corsera Health is an ambitious, early-stage biotech founded by industry luminaries John Maraganore and Clive Meanwell, aiming to redefine cardiovascular health through prediction and prevention. The company's strategy combines a proprietary AI tool, 'Klotho,' for assessing lifetime cardiovascular risk with the development of preventive RNAi medicines targeting key drivers like high LDL cholesterol and hypertension. With a leadership team that pioneered RNAi therapeutics and built multi-billion dollar cardiovascular companies, Corsera is positioned to pursue a disruptive, population-health-focused business model, though its programs are still in pre-clinical or early discovery stages.
View full company profile